title: Neurocognitive development of children born small for gestational age (SGA). An update.
abstract: The aim of the present study is to confirm that being born SGA is a serious risk for a negative neurocognitive development. 233 cases have been controlled yearly and longitudinally by the same investigator, some of them 11 times, showing 25,8 % an IQ less than 2 SD, being less affected the catch-up + group (15 %), compared to the catch-up - group (31,4 %). The GH therapy (n 64) started before the age of 6 (n 38) or after 6 (n 26), doesn't improve the negative outcome.
authors.affiliation: Andrea Prader Foundation, IACS (Instituto de Ciencias de La Salud - Institute of Health Sciences), Government of Aragon.
authors.forename: Beatriz
authors.initials: B
authors.lastname: Puga
authors.forename: Paloma
authors.initials: P
authors.lastname: Gil
authors.forename: Antonio
authors.initials: A
authors.lastname: de Arriba
authors.forename: José Ignacio
authors.initials: JI
authors.lastname: Labarta
authors.forename: Agustín
authors.initials: A
authors.lastname: Romo
authors.forename: Esteban
authors.initials: E
authors.lastname: Mayayo
authors.forename: Angel
authors.initials: A
authors.lastname: Ferrández Longás
mesh_terms: D000293:Adolescent; D001921:Brain / Q000254:growth & development*; D002648:Child; D002675:Child, Preschool; D003071:Cognition / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D006130:Growth Disorders / Q000188:drug therapy* / Q000453:epidemiology; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age / Q000254:growth & development*; D008137:Longitudinal Studies; D008297:Male; D012307:Risk Factors
chemical_list: D019382:Human Growth Hormone